CIK 0001893219 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Abpro Holdings, Inc.
Sign in to watch- Tickers
- ABPO ABPWW
- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 871013956
- Phone
- 248-890-7200
- Business address
- 6 ST JOHNS LANE, FLOOR 5, NEW YORK, NY, 10013
- Former names
- Atlantic Coastal Acquisition Corp. II
Securities
- ABPO Common stock OTC
- ABPWW Common stock OTC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-07-31 | Suk Jin Wook (Miles) CEO and Chairman | Purchase | +72,035 | $0.28 | $20K | 718,512 |
| 2025-07-25 | Lee Soo Young Director | Grant or award · Stock option (right to buy) | +60,600 | 60,600 | ||
| 2025-07-25 | Eisenberg Anthony D. Director | Grant or award · Stock option (right to buy) | +60,600 | 60,600 | ||
| 2025-07-25 | Suk Jin Wook (Miles) CEO and Chairman | Grant or award | +500,000 | 646,477 | ||
| 2025-05-19 | Suk Jin Wook (Miles) CEO and Chairman | Purchase | +16,200 | $0.26 | $4K | 146,477 |
| 2025-04-29 | Suk Jin Wook (Miles) CEO and Chairman | Purchase | +4,325 | $0.25 | $1K | 130,277 |
| 2025-04-24 | Suk Jin Wook (Miles) CEO and Chairman | Purchase | +26,542 | $0.34 | $9K | 125,902 |
| 2025-04-23 | Suk Jin Wook (Miles) CEO and Chairman | Purchase | +7,460 | $0.28 | $2K | 99,360 |
| 2024-11-13 | Suk Jin Wook (Miles) Co-CEO & Chairman | Grant or award · Stock option (right to buy) | +613,500 | 613,500 | ||
| 2024-11-13 | Chan Ian Chief Executive Officer | Grant or award | +6,528,200 | 6,528,200 | ||
| 2024-11-13 | Chan Ian Chief Executive Officer | Grant or award | +1,137,200 | 1,137,200 | ||
| 2024-11-13 | Chan Ian Chief Executive Officer | Grant or award | +987,400 | 987,400 | ||
| 2024-11-13 | Chan Ian Chief Executive Officer | Grant or award · Stock option (right to buy) | +777,100 | 777,100 | ||
| 2024-11-13 | Chan Ian Chief Executive Officer | Grant or award · Stock option (right to buy) | +787,300 | 787,300 | ||
| 2024-11-13 | Chan Ian Chief Executive Officer | Grant or award · Stock option (right to buy) | +787,300 | 787,300 | ||
| 2024-11-13 | Chan Ian Chief Executive Officer | Grant or award · Stock option (right to buy) | +577,500 | 577,500 | ||
| 2024-11-13 | Suk Jin Wook (Miles) Co-CEO & Chairman | Grant or award | +91,900 | 91,900 | ||
| 2024-11-13 | Markelewicz Robert J. Jr. Chief Medical Officer | Grant or award · Stock option (right to buy) | +24,300 | 24,300 | ||
| 2024-11-13 | Markelewicz Robert J. Jr. Chief Medical Officer | Grant or award · Stock option (right to buy) | +538,600 | 538,600 | ||
| 2024-11-13 | Markelewicz Robert J. Jr. Chief Medical Officer | Grant or award · Stock option (right to buy) | +29,800 | 29,800 |
Page 1 of 3 · 41 trades